Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Solifenacin manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : Greece

Clear all

4 products found

solifenacin

Tablets, film coated 5 mg, 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Philippines , Vietnam
Registered in
Greece , Portugal
Available for
Licensing with supply, Distribution only
MAs for sale
Portugal
Manufacturer #271
A pharmaceutical manufacturer based in the EU that is active in 30+ countries selling its products in Europe, Africa, the Middle East, and Asia for 50+ years. The company's production lines are EU GMP-compliant. Key production lines are Rx, OTC, nutraceuticals, infant nutrition, and cosmetics. Main therapeutic areas include dermatology, antibiotics, and oncology.

Manufacturer usually replies in 9 days

solifenacin

Tablets, chewable 5 mg, 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

solifenacin

Tablets, film coated 5 mg, 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

mirabegron + solifenacin

Tablets, film coated 25 mg + 5 mg, 50 mg + 5 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Reference product: Betmiga + Vesicare
Manufacturer #19112
A pharmaceutical manufacturer based in the EU that develops and produces generic medicines and sells its products in the EU, North America, LATAM, and Africa. Main therapeutic areas include diabetes, urology, and antidepressant. The company possesses its own R&D and regulatory department.

Manufacturer usually replies in 6 days

SOLIFENACIN

Solifenacin is an antimuscarinic medication. It treats overactive bladder, a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination. Solifenacin is also used to treat neurogenic detrusor overactivity, a condition in which a bladder control condition caused by a brain, spinal cord or nerve problem in children 2 years of age and older. Solifenacin is called an antimuscarinic, they work by relaxing the bladder muscles.
Solifenacin is sold under the brand name Vesicare among others. Yamanouchi Pharma America, Inc studied the compound using animal models in the early 2000s. Solifenacin was first approved for sale in the United States in 2004 with an indication to treat overactive bladder in adults older than 18 years. In May 2020, FDA to treat neurogenic detrusor overactivity (NDO), a form of bladder dysfunction related to neurological impairment, in children ages two years and older, approved Solifenacin.

Forms and dosage:

The Usual Adult Dose recommended for treating Urinary Incontinence is an initial dose of 5 mg, orally, once daily. This is followed by a maintenance dose of 5 to 10 mg, taken orally, once a day. For treating overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency, the usual adult dose starts with 5 mg, followed by a maintenance dose of 5 to 10 mg, taken orally, once daily.

The cost of Solifenacin

As of 2019, consumers in the United Kingdom paid about £27.62 for a month's supply. However, this is significantly higher in the United States, with the cost of the same supply is about US$370.

How does it work?

Its action improves the ability of the patient to control urination by relaxing the muscles in the bladder. It also reduces leaking of urine, urges to urinate urgently and reduces the frequency of trips to the washroom. To elaborate, it works as a competitive cholinergic receptor antagonist, selective for the M3 receptor subtype. When acetylcholine binds to these receptors, particularly M3, it makes contraction of smooth muscle possible. This medicine prevents the binding of acetylcholine to these receptors, thus reducing the smooth muscle tone in the bladder. The overall effects of the activity increase the bladder’s ability to retain larger volumes of urine and reducing the number of micturition, urgency and incontinence episodes.

Finding Solifenacin Manufacturers and Suppliers:

The process of finding trusted Solifenacin manufacturers and Solifenacin suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities.
The robust search engine makes it convenient to search for manufacturers and suppliers of Solifenacin. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.